Eating Behavior in Menopausal Women: From Molecular to Clinical Aspects-What Changes?
- 1Department of Clinical and Experimental Medicine, University of Catani a, Via Santa Sofia 78, 95123 Catania, Italy.
Abstract
The menopausal transition represents a critical period in women's lives characterized by profound hormonal, metabolic, and behavioral changes. Estrogen deficiency during menopause triggers complex alterations in eating behavior through multiple molecular mechanisms involving hypothalamic neuropeptide systems, neurotransmitter pathways, and peripheral hormonal signals. This narrative review examines the molecular basis of eating behavior changes in menopausal women, integrating evidence from basic science and clinical research. At the molecular level, declining estradiol disrupts the hypothalamic regulation of appetite through estrogen receptors ERα and ERβ, leading to dysregulation of key neuropeptides including neuropeptide Y (NPY), agouti-related peptide (AgRP), and proopiomelanocortin (POMC). Peripheral signals such as leptin, ghrelin, and insulin show altered secretion and sensitivity patterns. Clinically, postmenopausal women experience increased appetite, heightened food reward sensitivity, carbohydrate cravings, and elevated risk of binge eating behaviors. These changes contribute to weight gain averaging 2-3 kg during the menopausal transition, with preferential visceral fat accumulation increasing metabolic syndrome risk. Body composition shifts include 44% increases in visceral adiposity and concurrent sarcopenia. Emerging evidence highlights the role of gut microbiota alterations in mediating metabolic dysfunction. Therapeutic strategies including hormone replacement therapy, targeted nutritional interventions, and lifestyle modifications show promise in mitigating these changes. Understanding the molecular-to-clinical continuum of eating behavior changes in menopause is essential for developing evidence-based preventive and therapeutic approaches to improve metabolic health and quality of life in postmenopausal women.
Related
- Supporting engagement, behavior change, and equitable self-management in menstrual and menopausal health: A multi-agent digital-health framework
- Comparison of intraoperative hemodynamic changes and recovery outcomes between non-menopausal and postmenopausal women undergoing total abdominal hysterectomy under general anesthesia.
- Dynamic Urothelial Remodeling in Diabetic Bladder Dysfunction: Disease-Course Changes, Molecular Mechanisms, and Clinical Implications
- The therapeutic landscape of cannabidiol: a systematic review of molecular mechanisms, clinical efficacy in oncology and neurology, and regulatory changes.
- Early Changes in Myocardial Mechanics and Diastolic Function in Women During the Menopausal Transition
BibTeX
@article{vignera2026eating,
title = {{Eating Behavior in Menopausal Women: From Molecular to Clinical Aspects-What Changes?}},
author = {Sandro La Vignera and Aldo E Calogero and Rossella Cannarella and Andrea Crafa and Federica Barbagallo and Rosita A Condorelli},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
doi = {10.3390/ijms27198538},
url = {https://europepmc.org/article/MED/42883785},
note = {CC BY},
}
RIS
TY - JOUR
TI - Eating Behavior in Menopausal Women: From Molecular to Clinical Aspects-What Changes?
AU - Sandro La Vignera
AU - Aldo E Calogero
AU - Rossella Cannarella
AU - Andrea Crafa
AU - Federica Barbagallo
AU - Rosita A Condorelli
PY - 2026
DA - 2026/09/24
JO - International journal of molecular sciences
DO - 10.3390/ijms27198538
UR - https://europepmc.org/article/MED/42883785
AB - The menopausal transition represents a critical period in women's lives characterized by profound hormonal, metabolic, and behavioral changes. Estrogen deficiency during menopause triggers complex alterations in eating behavior through multiple molecular mechanisms involving hypothalamic neuropeptide systems, neurotransmitter pathways, and peripheral hormonal signals. This narrative review examines the molecular basis of eating behavior changes in menopausal women, integrating evidence from basic science and clinical research. At the molecular level, declining estradiol disrupts the hypothalamic regulation of appetite through estrogen receptors ERα and ERβ, leading to dysregulation of key neuropeptides including neuropeptide Y (NPY), agouti-related peptide (AgRP), and proopiomelanocortin (POMC). Peripheral signals such as leptin, ghrelin, and insulin show altered secretion and sensitivity patterns. Clinically, postmenopausal women experience increased appetite, heightened food reward sensitivity, carbohydrate cravings, and elevated risk of binge eating behaviors. These changes contribute to weight gain averaging 2-3 kg during the menopausal transition, with preferential visceral fat accumulation increasing metabolic syndrome risk. Body composition shifts include 44% increases in visceral adiposity and concurrent sarcopenia. Emerging evidence highlights the role of gut microbiota alterations in mediating metabolic dysfunction. Therapeutic strategies including hormone replacement therapy, targeted nutritional interventions, and lifestyle modifications show promise in mitigating these changes. Understanding the molecular-to-clinical continuum of eating behavior changes in menopause is essential for developing evidence-based preventive and therapeutic approaches to improve metabolic health and quality of life in postmenopausal women.
SN - 1422-0067
ER -